MedPath

Response Inhibition in Tourette Syndrome

Not Applicable
Completed
Conditions
Tourette Syndrome
Interventions
Device: Repetitive TMS
Registration Number
NCT03628703
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
Brief Summary

Tics are the hallmark symptoms in Tourette Syndrome. Patients with Tourette Syndrome have difficulties controlling unwanted movements. The ability to control the motor system involves the pre-supplementary motor area (pre-SMA) in the brain. In this study, we will use Transcranial Magnetic Stimulation to modulate the pre-SMA and determine effect on the ability to stop an unwanted action in a behavior task (stop signal task).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Tourette Syndrome
Exclusion Criteria
  • Autism spectrum disorder
  • Mood disorder
  • Epilepsy
  • Implanted medical device (e.g. pacemaker, shunt, pumps)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Repetitive TMSRepetitive TMSRepetitive Intermittent Theta-Burst Transcranial Magnetic Stimulation
Primary Outcome Measures
NameTimeMethod
Stop Signal Reaction Time (SSRT)30 minutes after Repetitive Transcranial Magnetic Stimulation (as it takes about 30 minutes to complete the modified Slater-Hammel stop signal task)

SSRT measured from modified Slater-Hammel stop signal task performance. The SSRT is calculated by subtracting the average stop signal delay (msec) from the average go-trial reaction time. The SSRT is a measure of inhibitory behavior. The lower the SSRT value means a person is better at inhibitory control. The higher the SSRT value means a person is worse at inhibitory control.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cincinnati Children's Hospital Medical Center

🇺🇸

Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath